Genetic testing company 23andMe has filed for bankruptcy, raising concerns about the fate of its customers' genetic data. Despite uncertainties, experts see the value in genetic information for medical research, advertising, and personalized products. The company plans to continue operations and ensure data privacy under new ownership.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing